Resistance to platinum chemotherapy in lung adenocarcinoma is driven by a non-genetic, cell-cycle dependent mechanism

Álvaro González-Rajal(Garvan Institute of Medical Research), Andrew Burgess(Garvan Institute of Medical Research)
Research Explorer (The University of Manchester)
May 5, 2021
Cited by 0


Related Papers